B. Braun Medical has launched a “supply assurance program” aimed at strengthening the resilience of the medical device and pharmaceutical supply chain.
The program guarantees 45 days of inventory on hand at key distributor warehouse locations — compared to the typical 24 to 28 days — and maintains additional safety stock at B. Braun’s three U.S. warehouses, according to a Dec. 15 news release. No contracts or additional costs are required for customers.
The initiative covers B. Braun’s full product portfolio, including IV solutions, vascular access devices, pain control products and closed-system transfer devices. By positioning inventory closer to healthcare providers, the company aims to ensure uninterrupted access to critical supplies during periods of high demand or disruption, it said.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.